Short Course : LC-MSMS 101 : Getting Started with Quantitative LC-MSMS in the Diagnostic Laboratory
Location: De Anza 2 (Portola Hotel > Ground Floor)
800
1200
Short Course : LC-MSMS 201 : Practical LC-MS/MS Method Development and Bioanalytical Method Validation for Clinical and Non-Clinical Samples
Location: Ironwood 2 (Portola Hotel > 3rd Floor)
800
1200
Short Course : LC-MSMS 203 : Validation of Quantitative LC-MS/MS Assays for Clinical and Academic Use
Location: De Anza 3 (Portola Hotel > Ground Floor)
Claire Knezevic, PhD Lurie Childrens Hospital
Dr. Claire Knezevic is a clinical chemist in the Department of Pathology and Laboratory Medicine at Lurie Children's Hospital with a focus on chemistry, point-of-care testing, quality improvement, drug monitoring, and personalized medicine. She is an Associate Professor in Northwestern's Feinberg School of Medicine in the Department of Pathology. Her interests include all things small molecule, from toxicology to therapeutic drug monitoring and their impacts on clinical care.
Relevant Financial Disclosures
(within past 24 months, reported on Mar 06, 2026)
No relevant financial relationship(s) to disclose.
Joshua Hayden, PhD, DABCC, FACB Cleveland Clinic
Joshua is currently the Section Head of Clinical Biochemistry at Cleveland Clinic. He earned his PhD in chemistry from Carnegie Mellon University. He conducted postdoctoral research at Massachusetts Institute of Technology before completing a two-year clinical chemistry fellowship at University of Washington and 4 years as Assistant Professor at Weill Medical College. Joshua has special expertise developing and overseeing mass spectrometry assays in the clinical laboratory.
Relevant Financial Disclosures
(within past 24 months, reported on Feb 27, 2026)
Honorarium/Expenses
Thermo (speaker)
Committee/Board/Advisory Board
BioPorto (ended)
800
1200
Short Course : LC-MSMS 302 : Advanced LC-MS/MS Method Development, Method Troubleshooting and Instrument Operation Needed in Developing Successful Methods for Molecular identification and Quantitation in the Clinical Lab
Short Course : Data Science 101 : Breaking up with Excel: An Introduction to the R Statistical Programming Language
Location: Colton 1/2 (Conference Ctr > 2nd Floor)
800
1200
Short Course : Data Science 203 : Machine Learning : A Gentle Introduction
Location: Bonsai (Portola Hotel > Ground Floor)
800
1200
Short Course : Sample Preparation 201 : Sample Preparation and Alternative Matrices for LC-MS Assays
Location: Redwood 2 (Portola Hotel > 3rd Floor)
William Clarke, PhD, MBA, DABCC Johns Hopkins University School of Medicine
Dr. Clarke received his Ph.D. in Analytical Chemistry from the University of Nebraska in Lincoln in 2000, followed by a post-doctoral fellowship in Clinical Chemistry at the Johns Hopkins School of Medicine, ending in 2002. In addition, he received an MBA focused on medical services management from the Carey School of Business at Johns Hopkins in 2007. Following his post-doctoral fellowship, he remained at Johns Hopkins, where he is a Professor in the Department of Pathology, as well as the director of Point-of-Care Testing, Reference Toxicology, and Phlebotomy for the hospital. He also serves as the Vice-Chair for Quality and Regulatory Affairs in the Department of Pathology. His research interests include clinical mass spectrometry, method development and evaluation for therapeutic drug monitoring, clinical toxicology, point-of-care testing, and development/validation of biomarkers for use in drug management. Dr. Clarke has published as author or co-author over 170 peer-reviewed manuscripts or book chapters, and is the Co-Editor of the textbook Contemporary Practice in Clinical Chemistry.
Relevant Financial Disclosures
(within past 24 months, reported on Feb 27, 2026)
Consultant Fees
Roche
Grant/Research Support
Thermo Fisher, Danaher, Roche
Committee/Board/Advisory Board
Roche, Truvian
Mark Marzinke, PhD, DABCC, FAACC Johns Hopkins University School of Medicine
Dr. Mark Marzinke is Professor of Pathology and Medicine in the Johns Hopkins University School of Medicine. He is board-certified in Clinical Chemistry by the American Board of Clinical Chemistry. He serves as the Director of the General Chemistry Laboratory at the Johns Hopkins Hospital and the Clinical Pharmacology Analytical Laboratory within the Division of Clinical Pharmacology. Dr. Marzinke is Co-Principal Investigator (PI) of the HIV Prevention Trials Network (HPTN) Laboratory Center (LC) and is the Director of the Clinical Laboratory Core for the Johns Hopkins Center for AIDS Research. His primary research interests are in the areas of antiretroviral pharmacology, HIV prevention science, mass spectrometry, pharmacogenetics and precision medicine, and laboratory automation. Dr. Marzinke has an active research program and serves as a principal investigator (PI) or co-investigator on a number of grants. He has collaborated on research to better characterize the multi-compartment pharmacology of antiretroviral agents when administered using alternative drug delivery systems using liquid chromatographic-mass spectrometric approaches. He has published more than 180 peer-reviewed articles, and holds leadership positions in several societies.
Relevant Financial Disclosures
(within past 24 months, reported on Mar 06, 2026)
No relevant financial relationship(s) to disclose.
800
1200
Short Course : Metabolomics 102 : Microsampling and Mass Spectrometry – Fit for Purpose in the Clinical Screening and Monitoring Space
Location: Cottonwood 1 (Portola Hotel > 3rd Floor)
800
1200
Short Course : Clinical Proteomics 201 : Clinical Proteomics
Dr. Hoofnagle's laboratory focuses on the precise quantification of recognized protein biomarkers in human plasma using LC-MRM/MS. In addition, they have worked to develop novel assays for the quantification of small molecules in clinical and research settings. His laboratory also studies the role that the systemic inflammation plays in the pathophysiology of obesity, diabetes, and cardiovascular disease.
Relevant Financial Disclosures
(within past 24 months, reported on Feb 27, 2026)
Grant/Research Support
Waters, Inc.
Cory Bystrom, PhD Ultragenyx
Relevant Financial Disclosures
(within past 24 months, reported on Feb 27, 2026)
Stock/Bonds
Ultragenyx
Salary
Ultragenyx
Christopher Shuford, PhD Labcorp
Chris Shuford, Ph.D., is Associate Vice President and Technical Director for research and development at Laboratory Corporation of America in Burlington, North Carolina. Chris received his B.S. in Chemistry & Physics at Longwood University and obtained his Ph.D. in Bioanalytical Chemistry from North Carolina State University under the tutelage of Professor David Muddiman, where his research focused on applications of nano-flow chromatography for multiplexed peptide quantification using protein cleavage coupled with isotope dilution mass spectrometry (PC-IDMS). In 2012, Chris joined LabCorp’s research and development team where his efforts have focused on development of high-flow chromatographic methods (>1 mL/min) for multiplexed and single protein assays for clinical diagnostics.
Relevant Financial Disclosures
(within past 24 months, reported on Feb 27, 2026)
Stock/Bonds
Laboratory Corporation of America
Salary
Laboratory Corporation of America
800
1200
Short Course : Clinical Proteomics 202 : MS-based Precision Diagnostics by Molecular Protein Analysis
Location: Ironwood 1 (Portola Hotel > 3rd Floor)
Renee Ruhaak, PhD LUMC
Renee Ruhaak holds a PhD from the Leiden University Medical Center (LUMC, supervisor Prof. M. Wuhrer) and did a post-doc at UC Davis in the lab of Prof. C.B. Lebrilla prior to joining the department of Clinical Chemistry and Laboratory Medicine at the LUMC. She is currently an associate professor with a research focus on the application of mass spectrometry within the clinical setting. This entails both development and implementation of quantitative protein mass spectrometry, as well as the role of mass spectrometry in metrology and test standardization.
Relevant Financial Disclosures
(within past 24 months, reported on Feb 27, 2026)
Grant/Research Support
Octapharma
Mirjam Kruijt, PhD Amsterdam UMC
Relevant Financial Disclosures
(within past 24 months, reported on Jun 27, 2025)
No relevant financial relationship(s) to disclose.
Esther Reijnders, MSc. LUMC
Esther is currently working as a 4th year PhD-student in the lab of prof. dr. Christa Cobbaert under the supervision of dr. Renee Ruhaak at Leiden University Medical Center in the Netherlands. Her research primarily focuses on evaluating the clinical effectiveness of a multiplex mass spectrometry-based apolipoprotein panel for cardiovascular risk prediction.
Relevant Financial Disclosures
(within past 24 months, reported on Feb 13, 2024)
Not yet reported.
800
1200
Short Course : GlycoProteomics 101 : Clinical Glyco(proteo)mics by Mass Spectrometry
Location: Cottonwood 2 (Portola Hotel > 3rd Floor)
Tamás Pongrácz, PhD Karolinska Institute
I am an analytical chemist with expertise in developing and refining advanced analytical methods and bioinformatics tools for high-throughput, mass spectrometry-based analysis of complex sugar molecules (glycans) that are key structural components of most proteins, including antibodies.
My research focuses on exploring the glycomic landscape of human diseases, elucidating the link between antibody glycosylation and function, and contextualizing these findings within clinical disease proxies across various conditions.
Currently, I am a postdoctoral researcher and bioinformatician in the group of Charlotte Thålin at Karolinska Institute, where we investigate the role of IgA glycosylation in mucosal immunity. This position has provided an ideal continuation of my academic career path following a PhD and postdoctoral training at Leiden University Medical Center, where I worked in a highly interdisciplinary environment at the interface of analytical chemistry, bioinformatics and clinical research.
Driven by a strong commitment to translational science, bridging the gap between fundamental research and patient care is my major ambition. I believe that glycan-based diagnostics and therapeutics hold transformative potential and will play a central role in the next generation of medical innovation.
Relevant Financial Disclosures
(within past 24 months, reported on Apr 29, 2025)
No relevant financial relationship(s) to disclose.
Guinevere Lageveen-Kammeijer, PhD University of Groningen
Dr. Guinevere Lageveen-Kammeijer is an Assistant Professor in the Analytical Biochemistry group at the University of Groningen, within the Groningen Research Institute of Pharmacy. She holds a BSc in Biotechnology - Forensic Sciences from the University of Applied Sciences van Hall Larenstein, Leeuwarden, and an MSc in Analytical Chemistry from VU University, Amsterdam. Her research interests were ignited during her MSc internship, where she focused on separation techniques coupled with mass spectrometry.
Guinevere earned her PhD in Clinical Glycomics from the Leiden University Medical Center in 2019 under the supervision of Prof. Manfred Wuhrer. Her thesis developed small-scale sample preparation workflows using capillary electrophoresis (CE) and mass spectrometry (MS/MS) to analyze glycans, glycopeptides, and glycoproteins, with applications in biomarker discovery and biopharmaceutical characterization. She continued her research as a post-doctoral researcher at the same institution before expanding her expertise with a visit to Northeastern University, Boston, in 2017, where she focused on protein charge and proteoform heterogeneity.
In 2022, Guinevere began her tenure-track assistant professorship at the University of Groningen, where she works on advancing glyco(proteo)mic techniques, particularly in single-cell glycomic analysis. Her research includes expanding the mass spectrometry-based glycosylation assay for prostate-specific antigen (PSA), a key biomarker for prostate cancer, and exploring the in-depth analysis of glycans and glycoproteins for biomarker discovery in other diseases and biopharmaceutical characterization.
Guinevere’s contributions have been recognized through funding such as the Investigator Sponsored Research grant from Astellas (2019) and the prestigious NWO VENI grant (2023). She is actively involved in the scientific community, serving on the Scientific Omics Committee for MSACL. Guinevere is passionate about promoting the importance of glycosylation in biomarker research, aiming to bridge the gap between researchers and clinical professionals to improve biomarker translation to the clinic.
Relevant Financial Disclosures
(within past 24 months, reported on Mar 18, 2025)
No relevant financial relationship(s) to disclose.
Short Course : LC-MSMS 101 : Getting Started with Quantitative LC-MSMS in the Diagnostic Laboratory
Location: De Anza 2 (Portola Hotel > Ground Floor)
1400
1800
Short Course : LC-MSMS 201 : Practical LC-MS/MS Method Development and Bioanalytical Method Validation for Clinical and Non-Clinical Samples
Location: Ironwood 2 (Portola Hotel > 3rd Floor)
1400
1800
Short Course : LC-MSMS 203 : Validation of Quantitative LC-MS/MS Assays for Clinical and Academic Use
Location: De Anza 3 (Portola Hotel > Ground Floor)
1400
1800
Short Course : LC-MSMS 302 : Advanced LC-MS/MS Method Development, Method Troubleshooting and Instrument Operation Needed in Developing Successful Methods for Molecular identification and Quantitation in the Clinical Lab
Short Course : Data Science 101 : Breaking up with Excel: An Introduction to the R Statistical Programming Language
Location: Colton 1/2 (Conference Ctr > 2nd Floor)
1400
1800
Short Course : Data Science 201 : Flexing with R : Databases to Dashboards
Location: Colton 3 (Conference Ctr > 2nd Floor)
Shannon Haymond, PhD Northwestern University Feinberg School of Medicine
My lab performs research and clinical testing using mass spectrometry methods, develops new assays, and applies data analytics to enable improved quality and efficiency. My computational pathology efforts are aimed at building the capacity for advanced data analytics in the department through innovations in infrastructure, education, and research to facilitate data-informed decision making for clinical care, operations, and quality assurance.
Relevant Financial Disclosures
(within past 24 months, reported on Feb 27, 2026)
Committee/Board/Advisory Board
Roche Diagnostics (ended)
Patrick Mathias, MD, PhD University of Washington
Patrick Mathias, M.D., Ph.D., is a board-certified clinical pathologist and Associate Director of Informatics for UW Laboratory Medicine.
Lab medicine has large impact on the general practice of medicine. It is key to correctly diagnosing diseases and selecting the right treatments for patients. Dr. Mathias's goal is to combine technical and medical knowledge to fulfill the triple aim--reduce the per capita cost of health care, improve the health of populations and most importantly improve the patient experience of care.
Dr. Mathias earned his M.D. and Ph.D. from the University of Illinois. His clinical and research interests include clinical informatics, clinical chemistry and molecular diagnostics.
Relevant Financial Disclosures
(within past 24 months, reported on Feb 27, 2026)
Stock/Bonds
Amgen, Corcept Therapeutics, Monte Rosa Therapeutics
1400
1800
Short Course : Data Science 203 : Machine Learning : A Gentle Introduction
Location: Bonsai (Portola Hotel > Ground Floor)
1400
1800
Short Course : Sample Preparation 201 : Sample Preparation and Alternative Matrices for LC-MS Assays
Location: Redwood 2 (Portola Hotel > 3rd Floor)
1400
1800
Short Course : Metabolomics 203 : Practical Bioinformatics and Statistics in Metabolomics
Location: Cottonwood 1 (Portola Hotel > 3rd Floor)
Tim Garrett, PhD University of Florida College of Medicine
Dr. Garrett has over 20 years of experience in the field of mass spectrometry spanning both instrument and application development. He received his PhD from the University of Florida, under Dr. Richard A. Yost, working on the first imaging mass spectrometry-based ion trap instrument. He has also developed MALDI-based approaches to analyze proteins in bacteria and small molecules in tissue specimens. His current interests include development of techniques and instrumentation for metabolomics science using LC-HRMS and translational work in diagnostics for dried blood spots. He is an Associate Professor in the Department of Pathology at the University of Florida, and Director for the Southeast Center for Integrated Metabolomics (SECIM).
Relevant Financial Disclosures
(within past 24 months, reported on Sep 11, 2025)
No relevant financial relationship(s) to disclose.
1400
1800
Short Course : Clinical Proteomics 201 : Clinical Proteomics
Short Course : Clinical Proteomics 202 : MS-based Precision Diagnostics by Molecular Protein Analysis
Location: Ironwood 1 (Portola Hotel > 3rd Floor)
1400
1800
Short Course : Lipidomics 101 : Mass Spectrometry-based Lipidomics and Clinical Applications
Location: Redwood 1 (Portola Hotel > 3rd Floor)
Anne K. Bendt, PhD Singapore Lipidomics Incubator (SLING), National University of Singapore
Anne K Bendt studied Biology focusing on marine biotechnology (Greifswald University, Germany), followed by a PhD in Biochemistry (Cologne University, Germany) employing proteomics and transcriptomics. Driven by her fascination for infectious diseases, she joined the National University of Singapore (NUS) in 2004 to develop lipidomics tools for tuberculosis studies. She is now a Principal Investigator at the Life Sciences Institute, NUS, focussing on translation of mass spec technologies into clinical applications, and serving as the Deputy Director of the Singapore Lipidomics Incubator (SLING) taking care of operations and commercialization.
Relevant Financial Disclosures
(within past 24 months, reported on Mar 05, 2026)
No relevant financial relationship(s) to disclose.
Amaury Cazenave Gassiot, PhD Singapore Lipidomics Incubator (SLING) and Department of Biochemistry, National University of Singapore
Research Assistant Prof. Cazenave-Gassiot is an early-career researcher and an expert in mass spectrometry-based lipidomics. He graduated with a PhD in analytical chemistry at the University of Southampton (UK), under the supervision of Dr John Langley, specialising in supercritical fluid chromatography and mass spectrometry. His interest in lipids started while a postdoc in the team of Professor Anthony Postle, still in Southampton. A member of SLING since 2009, his research centres on separation sciences, mass spectrometry, and their applications to life sciences, especially lipid biochemistry. He has developed chromatographic and mass spectrometric methods for the identification and quantification of lipids in diverse biological systems. This has included successful local and international collaborations.
Relevant Financial Disclosures
(within past 24 months, reported on Mar 05, 2026)
No relevant financial relationship(s) to disclose.
Michael Chen, MD MSc The University of British Columbia
Dr. Michael Chen is a clinical pathologist, specializing in clinical chemistry and translational mass spectrometry. He is the Department Head and Medical Director of Laboratory Medicine, Pathology and Medical Genetics at Island Health, and Provincial Discipline Lead at Provincial Health Services Authority. As a researcher, Dr Chen is the scientific director of UBC Translational Omics Lab in the Victoria General Hospital. He is also the director of Vancouver Island Biobank, and he co-chairs the BC Biobank Network. Dr. Chen’s research focuses on clinical mass spectrometry, biobanking, biomarker validation and clinical implementation.
Relevant Financial Disclosures
(within past 24 months, reported on Apr 18, 2026)
Ownership Interest
Pataigin Inc
1400
1800
Short Course : GlycoProteomics 101 : Clinical Glyco(proteo)mics by Mass Spectrometry
Location: Cottonwood 2 (Portola Hotel > 3rd Floor)
